SFL’s CEO Shayesteh Fürst-Ladani and Business Development and Project Manager Delphine Guerin, will participate in the upcoming 2019 BIO International Convention (3-6 June, Philadelphia, USA). The BIO international convention brings together over 16 000 biotechnology and pharma leaders to identify opportunities and partnerships in the biotechnology and pharmaceutical industries. Key areas at BIO this year include developments in drug discovery, genomics and cell therapy that compliments various aspects of SFL’s expertise areas, including gene therapy, precision medicines, digital health, regulations, innovation and patient access.

SFL provides both strategic as well as operational support for projects covering all life-cycle stages from early development to regulatory maintenance and commercialization of approved healthcare products, utilizing its unique combination of expertise and a multi-disciplinary approach. In addition, SFL Pharma also provides full support to pharma companies, who do not have a registered subsidiary in the EU or Switzerland, by acting as their Marketing Authorization Holder (MAH). Contact us to arrange a meeting with Shayesteh or Delphine during the BIO International Convention.